Net Pals Net Pals
Rezultatele cautarii
Vedeti tot
  • Conecteaza-te
    Conecteaza-te
    Inscrie-te
    Căutare
    Night Mode

Căutare

Descoperă oameni noi, creează noi conexiuni și faceti-va noi prieteni

  • News Feed
  • EXPLORE
  • Pagini
  • Grupuri
  • Events
  • Reels
  • Blogs
  • Anunturi
  • Offers
  • Jobs
  • Postari
  • Blogs
  • Utilizatori
  • Pagini
  • Grupuri
  • Events
  • EthanWalker a adăugat un sunet Alte
    2026-10-23 22:16:07 - Translate -
    Alvotech (ALVO) files first known Eylea 8 mg biosimilar application in Europe
    Alvotech and Advanz Pharma sent AVT29 to the European Medicines Agency on 14 October 2026 as a line extension to Mynzepli, the Eylea 2 mg biosimilar. Alvotech (ALVO) and its partner Advanz Pharma submitted AVT29 to the European Medicines Agency on 14 October 2026, according to a company release issued the same day. AVT29 is a proposed biosimilar to Eylea 8 mg, the higher-dose form of...
    0 Commentarii 0 Distribuiri 19 Views 0 previzualizare
    Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!
  • sarthak1234 a adăugat un sunet Health
    2026-08-11 12:10:33 - Translate -
    Daratumumab Injection Market: Competitive Landscape, Strategic Collaborations, and the Rise of Subcutaneous Formulations
    The Daratumumab Injection Market is a dynamic and highly competitive sector characterized by intense research and development activities, strategic collaborations, and a relentless pursuit of innovation. As the market is projected to reach USD 7.0 billion by 2035, growing at a CAGR of 10.1%, key players are actively seeking to differentiate themselves through advanced product...
    0 Commentarii 0 Distribuiri 5K Views 0 previzualizare
    Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!
© 2026 Net Pals Romaian
English Arabic French Spanish Portuguese Deutsch Turkish Dutch Italiano Russian Romaian Portuguese (Brazil) Greek
About Termeni Confidențialitate Cookies Acceptable Use Contacteaza-ne Director